Samples

Homo_sapiens Human ESCs

Name Experiment name Description Gender Genome build Mapping rate Uniquely mapping rate Genome coverage C coverage Depth BS-con Rate
Hom_ESCs_KO_DNMT3B_Rep1 ESCs_KO_DNMT3B_Rep1 H1 Human Embryonic Stem Cell (knock DNMT3B out), Replicate 1 - hg38 69.01% 64.12% 88.21% 90.64% 21.39 99.56%
Hom_EsophagusSquamousEpithelium_53yrs_Female EsophagusSquamousEpithelium_53yrs_Female Esophagus Squamous Epithelium from 53-year-old female adult Female hg38 71.22% 66.87% 87.50% 81.40% 22.14 99.57%
Hom_Normal_ESCs_KO_PWWPDomain_Rep1 Normal_ESCs_KO_PWWPDomain_Rep1 H1 Human Embryonic Stem Cell (knock PWWP domain out), Replicate 1 - hg38 83.52% 78.02% 88.29% 91.04% 22.33 99.52%
Hom_Normal_ESCs_KO_PWWPDomain_Rep2 Normal_ESCs_KO_PWWPDomain_Rep2 H1 Human Embryonic Stem Cell (knock PWWP domain out), Replicate 2 - hg38 83.28% 77.50% 88.26% 90.83% 19.96 99.54%
Hom_Tumor_EsophagealSquamouseCarcinoma_T11N0M0_Rep1 Tumor_EsophagealSquamouseCarcinoma_T11N0M0_Rep1 Esophageal Squamouse Carcinoma (moderately differentiated tumor pathological stage;T11N0M0), Replicate 1 - hg38 83.67% 77.86% 87.60% 88.99% 19.18 99.61%
Hom_Tumor_EsophagealSquamouseCarcinoma_T11N0M0_Rep2 Tumor_EsophagealSquamouseCarcinoma_T11N0M0_Rep2 Esophageal Squamouse Carcinoma (moderately differentiated tumor pathological stage;T11N0M0), Replicate 2 - hg38 85.42% 79.29% 87.15% 88.70% 22.36 99.62%
Hom_Tumor_EsophagealSquamouseCarcinoma_T11N0M0_Rep3 Tumor_EsophagealSquamouseCarcinoma_T11N0M0_Rep3 Esophageal Squamouse Carcinoma (highly or moderately differentiated tumor pathological stage;T11N0M0), Replicate 3 - hg38 84.69% 79.25% 87.41% 89.00% 19.92 99.60%
Hom_Tumor_EsophagealSquamouseCarcinoma_T11N0M0_Rep4 Tumor_EsophagealSquamouseCarcinoma_T11N0M0_Rep4 Esophageal Squamouse Carcinoma (moderately or poorly differentiated tumor pathological stage;T11N0M0), Replicate 4 - hg38 84.24% 77.66% 87.33% 88.42% 19.58 99.56%
Hom_Tumor_EsophagealSquamouseCarcinoma_T11N1aM0_Rep1 Tumor_EsophagealSquamouseCarcinoma_T11N1aM0_Rep1 Esophageal Squamouse Carcinoma (moderately differentiated tumor pathological stage;T11N1aM0), Replicate 1 - hg38 84.36% 78.47% 87.76% 89.32% 20.40 99.61%
Hom_Tumor_EsophagealSquamouseCarcinoma_T11N1aM0_Rep2 Tumor_EsophagealSquamouseCarcinoma_T11N1aM0_Rep2 Esophageal Squamouse Carcinoma (moderately differentiated tumor pathological stage;T11N1aM0), Replicate 2 - hg38 85.43% 79.44% 87.30% 88.68% 20.35 99.55%
Hom_Tumor_EsophagealSquamouseCarcinoma_T1bN0M0 Tumor_EsophagealSquamouseCarcinoma_T1bN0M0 Esophageal Squamouse Carcinoma (moderately differentiated tumor pathological stage;T1bN0M0) - hg38 85.49% 79.23% 87.13% 88.75% 18.40 99.48%
Hom_Tumor_EsophagealSquamouseCarcinoma_T2N0aM0 Tumor_EsophagealSquamouseCarcinoma_T2N0aM0 Esophageal Squamouse Carcinoma (moderately differentiated tumor pathological stage;T2N0aM0) - hg38 83.57% 77.37% 87.19% 88.54% 22.05 99.56%
Hom_Tumor_EsophagealSquamouseCarcinoma_T2N0M0 Tumor_EsophagealSquamouseCarcinoma_T2N0M0 Esophageal Squamouse Carcinoma (highly differentiated tumor pathological stage;T2N0M0) - hg38 84.55% 78.64% 87.40% 88.66% 19.45 99.48%
Hom_Tumor_EsophagealSquamouseCarcinoma_T2N1aM0 Tumor_EsophagealSquamouseCarcinoma_T2N1aM0 Esophageal Squamouse Carcinoma (highly or moderately differentiated tumor pathological stage;T2N1aM0) - hg38 85.26% 79.09% 87.64% 89.20% 20.25 99.61%